These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3627099)

  • 1. [Surgery of the patients on anticoagulants following prosthetic valve replacement].
    Kosuga K; Aoyagi S; Shima H; Yanagi I; Oryoji A; Oishi K; Koga M
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):779-84. PubMed ID: 3627099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term follow-up of aortic or mitral valve replacement. Comparison of results following implantation of a mechanical or biological artificial valve].
    Mudra H; Rudolph W
    Herz; 1986 Apr; 11(2):97-115. PubMed ID: 3699678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
    Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
    J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PT-INR as a parameter for anticoagulant therapy after valve replacement surgery].
    Ishibashi Y; Aoki H; Ohba J; Kamikubo Y; Morimoto K; Kumasaka A
    Kyobu Geka; 1996 Oct; 49(11):906-8. PubMed ID: 8913062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 11. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valve replacement surgery in patients with end-stage renal disease: long-term results.
    Gultekin B; Ozkan S; Uguz E; Atalay H; Akay T; Arslan A; Sezgin A; Ozdemir N; Tasdelen A; Aslamaci S
    Artif Organs; 2005 Dec; 29(12):972-5. PubMed ID: 16305653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in valvular heart disease preoperatively and postoperatively.
    Bodnar AG; Hutter AM
    Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].
    Colombo T; Cicardi C; Peronace B; Pozzi M; Gordini V; Pellegrini A
    G Ital Cardiol; 1985 Oct; 15(10):974-82. PubMed ID: 4092917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Carpentier-Edwards porcine bioprosthesis: assessment of a patient selection policy.
    Louagie Y; Noirhomme P; Aranguis E; Eucher P; Vanruyssevelt P; Buche M; Dion R; Jaumin P; Schoevaerdts JC; Chalant CH
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1013-24. PubMed ID: 1405658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.